By Stacey Johnson, Director of Communications, Centre for Commercialization of Regenerative Medicine
There is much joy and celebration in becoming a centenarian. This March, my grandmother turns 100. If she had one wish, I know it would be for renewed physical vitality. Her mind is strong, but her body is giving out.
Despite huge progress in research, there won’t be a cure for age-related macular degeneration in time for her to benefit, nor will she be able to replace her electronic pacemaker with one made from stem cells, but she’s excited by the promise of stem cell research, even if it won’t impact her directly.
Now is a time for optimism in the regenerative medicine (RM) field, especially in Canada. In October, the Canadian Stem Cell Foundation announced its national Stem Cell Strategy & Action Plan and barely a month later, the Province of Ontario awarded $3.1 million to launch the Ontario Institute for Regenerative Medicine (OIRM).
The regenerative medicine community in Canada is very connected thanks to more than a decade’s worth of targeted encouragement from the federal government – in the form of funding – and efforts by the Canadian Stem Cell Network to break down silos and promote collaboration. With all the key stakeholders working together to develop products and shepherd them through clinical trials to reach patients, the community has research excellence and political will on its side.
The Centre for Commercialization of Regenerative Medicine (CCRM), a unique not-for-profit group that is solely focused on developing and commercializing RM technologies, was involved with both of the recent announcements. The goal of the Stem Cell Strategy & Action Plan is to produce five to 10 therapies within the next 10 years. The OIRM has been established to translate stem cell research into curative therapies for major degenerative diseases. CCRM is the commercialization partner for both groups and is co-leading OIRM with the Ontario Stem Cell Initiative.
With an aging population and Canadian health care costs – direct and indirect – estimated at $190 billion annually, finding treatments and cures is imperative. The Canadian Stem Cell Foundation, OIRM and CCRM will coordinate efforts to move promising stem cell treatments from the bench to the bedside.
My grandmother is unlikely to see cures in her lifetime, but success is feeling closer every day. And that’s something worth celebrating.